Davidson Investment Advisors grew its stake in Cerner Co. (NASDAQ:CERN) by 0.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 143,777 shares of the company’s stock after acquiring an additional 405 shares during the quarter. Davidson Investment Advisors’ holdings in Cerner were worth $9,801,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Wealthcare Advisory Partners LLC boosted its stake in shares of Cerner by 185.9% during the third quarter. Wealthcare Advisory Partners LLC now owns 386 shares of the company’s stock valued at $26,000 after purchasing an additional 251 shares in the last quarter. Berman Capital Advisors LLC raised its position in shares of Cerner by 115.3% during the second quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares during the last quarter. Altshuler Shaham Ltd raised its position in shares of Cerner by 173.2% during the second quarter. Altshuler Shaham Ltd now owns 388 shares of the company’s stock worth $28,000 after acquiring an additional 246 shares during the last quarter. Enterprise Financial Services Corp raised its position in shares of Cerner by 142.8% during the third quarter. Enterprise Financial Services Corp now owns 420 shares of the company’s stock worth $29,000 after acquiring an additional 247 shares during the last quarter. Finally, CSat Investment Advisory L.P. raised its position in shares of Cerner by 119.7% during the second quarter. CSat Investment Advisory L.P. now owns 637 shares of the company’s stock worth $47,000 after acquiring an additional 347 shares during the last quarter. 84.54% of the stock is owned by institutional investors.

Shares of NASDAQ:CERN traded up $0.51 during mid-day trading on Tuesday, hitting $66.77. 8,738 shares of the company traded hands, compared to its average volume of 1,936,290. The stock has a market cap of $21.14 billion, a P/E ratio of 30.19, a P/E/G ratio of 2.11 and a beta of 0.92. The company has a current ratio of 2.21, a quick ratio of 2.19 and a debt-to-equity ratio of 0.24. Cerner Co. has a 12-month low of $48.78 and a 12-month high of $76.47. The stock has a 50-day moving average price of $67.38 and a two-hundred day moving average price of $69.73.

Cerner (NASDAQ:CERN) last announced its earnings results on Thursday, October 24th. The company reported $0.66 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.66. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Cerner had a return on equity of 15.61% and a net margin of 9.02%. Cerner’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.63 earnings per share. As a group, analysts expect that Cerner Co. will post 2.41 earnings per share for the current year.

In other Cerner news, VP Donald Trigg sold 29,423 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $67.72, for a total value of $1,992,525.56. Following the transaction, the vice president now owns 256,354 shares of the company’s stock, valued at $17,360,292.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Marc G. Naughton sold 24,110 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $67.58, for a total value of $1,629,353.80. Following the completion of the transaction, the chief financial officer now directly owns 84,898 shares in the company, valued at approximately $5,737,406.84. The disclosure for this sale can be found here. In the last three months, insiders sold 344,268 shares of company stock worth $23,243,010. Insiders own 0.75% of the company’s stock.

CERN has been the subject of a number of analyst reports. KeyCorp restated an “overweight” rating and set a $82.00 price objective (up from $76.00) on shares of Cerner in a research report on Friday, August 16th. Morgan Stanley lifted their target price on Cerner from $49.00 to $62.00 and gave the stock an “underweight” rating in a report on Friday, August 23rd. Bank of America set a $83.00 price objective on Cerner and gave the company a “buy” rating in a report on Friday, October 25th. Jefferies Financial Group downgraded Cerner from a “buy” rating to a “hold” rating and boosted their price objective for the company from $69.00 to $75.00 in a report on Friday, August 23rd. Finally, Citigroup boosted their price objective on Cerner from $77.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, July 25th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company. Cerner currently has an average rating of “Buy” and an average price target of $76.73.

Cerner Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Recommended Story: High-Yield Dividend Stocks

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.